Trial site
Toyama Prefectural Central Hospital
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Crohn's disease3 trials
- Heart failure2 trials
- Amyloidosis1 trial
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- IgA nephropathy1 trial
- Phase
- Phase 38 trials
- Phase 24 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Janssen Research & Development, LLC3 trials
- Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
- Janssen Pharmaceutical K.K.1 trial
- Medtronic Cardiac Ablation Solutions1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis1 recruiting
- Heart failure1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Terminated
Completed
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026